LUGELA in Traumatology, Orthopedics, and Rheumatology

Recovery after injury as a unified biological process

After damage to the musculoskeletal system, the body sequentially undergoes several interconnected stages:

• cleansing the injury area of damaged tissues;
• formation of new blood vessels;
• creation of a connective tissue matrix;
• restoration of bone, cartilage, or tendon structure;
• return of muscle strength and motor function;
• remodeling of the restored tissue according to load.

The result is determined by the stability of the damaged area, adequate blood supply, sufficient nutrition, mineral support, and properly organized rehabilitation.

LUGELA integrates into this system as a natural mineral complex supporting physiological processes related to the restoration of bone and muscle tissues.

Fractures and callus formation

Fracture healing passes through the inflammatory stage, formation of soft and hard callus, mineralization, and subsequent bone remodeling [1, 2].

At the mineralization stage, the forming organic matrix is saturated with mineral compounds. Calcium becomes a structural part of hydroxyapatite crystals, giving bone tissue density and mechanical strength.

Mineral support is especially important:

• in delayed union;
• in elderly age;
• after prolonged immobility;
• with decreased bone density;
• after complex and multiple fractures;
• during recovery after orthopedic surgeries.

LUGELA provides entry of natural ionized calcium as part of a multicomponent mineral matrix. Its role is maintaining calcium metabolism during the formation and remodeling of bone tissue.

Joints and periarticular tissues

Joint function depends on the condition of cartilage, subchondral bone, synovial membrane, capsule, ligaments, tendons, and muscles. Impairment of one element gradually alters loading on the entire joint complex.

In degenerative diseases, maintaining mineral metabolism combines with weight control, muscle strength recovery, and properly selected physical activity. This topic is discussed in detail in an article on osteoarthritis.

In this area, LUGELA's significance lies in supporting metabolic processes in bone tissue and neuromuscular function. Systemic intake is complemented by topical application to the affected joint and surrounding tissues.

Ligaments, tendons, and muscles

Ligaments and tendons regenerate slower than muscles due to their blood supply characteristics. Their regeneration requires preservation of collagen fiber integrity, sufficient protein intake, and gradual return of mechanical loading.

Calcium is not a structural component of collagen, but it is necessary for:

• muscle contraction and relaxation;
• nerve impulse transmission;
• movement coordination;
• cell signaling;
• joint stabilization by the muscular apparatus.

After injury, prolonged immobilization leads to muscle weakening and reduced bone loading. Therefore, mineral support must combine with stepwise rehabilitation. Too-early loading disrupts recovery, while excessively long immobilization increases loss of bone and muscle mass.

LUGELA in orthopedic rehabilitation

After injuries and surgeries, LUGELA usage is integrated into a sequential recovery program:

1. Stabilization of the damaged area.
2. Control of pain, swelling, and inflammatory response.
3. Course oral intake of LUGELA.
4. Topical application to the area of the local process.
5. Gradual restoration of range of motion.
6. Muscle strengthening and return of functional load.
7. Monitoring clinical and instrumental indicators.

This approach combines injury treatment, mineral support, and functional recovery. Outcome is assessed not only by well-being but also by objective data.

Fractures consider radiological signs of consolidation. After joint and ligament injuries, range of motion, joint stability, swelling severity, and load-bearing capability are evaluated. In the postoperative period, tissue condition and rehabilitation dynamics are additionally monitored.

LUGELA in rheumatology

Rheumatic diseases vary in origin and require different treatment approaches.

In degenerative and metabolic disorders, main tasks are:

• preserving mobility;
• strengthening the muscular apparatus;
• reducing excessive load;
• maintaining mineral metabolism;
• preventing deformities and bone mass loss.

In rheumatoid arthritis and other autoimmune diseases, the basis of treatment consists of drugs controlling immunoinflammatory activity. Contemporary guidelines recommend early initiation of basic antirheumatic therapy after diagnosis establishment [3].

LUGELA is used in these cases as part of comprehensive support of mineral metabolism, bone tissue, and neuromuscular function. It combines with prescribed therapy and does not replace drugs regulating the autoimmune process.

Such differentiation precisely defines the role of the natural healing factor in modern rheumatology.

Documented basis for use

Balneological and medical conclusions of 2023 classify musculoskeletal system and connective tissue diseases among the indications for LUGELA use.

Documents provide for oral and topical use of natural healing water. This allows combining systemic mineral impact with local application at the pathological site.

Scientific materials on LUGELA confirm:

• high content of natural ionized calcium;
• multicomponent nature of the mineral system;
• absorption characteristics;
• prolonged effect on calcium metabolism;
• independent pharmacodynamic profile of the natural complex.

The composition and differences of LUGELA from artificial calcium chloride solution are reviewed in separate articles of the Scientific Encyclopedia of LUGELA.

Course application scheme

The course basis is oral intake:

• the monthly course includes four bottles of 235 ml each;
• single dose for an adult does not exceed 10 ml;
• interval between doses is about five hours;
• one to two glasses of warm water are drunk 30 minutes before taking LUGELA;
• do not increase dosage independently.

Topical application

Topical application complements the oral course and is used on joints, ligaments, tendons, and surrounding soft tissues.

If skin or tissues are damaged, the treated area is not covered with a tight airtight dressing. For protection, a loose gauze covering in one or two layers is used, allowing air access and preventing a greenhouse effect.

In fractures, dislocations, and severe injuries, topical application does not replace immobilization, reduction, surgical treatment, and medical supervision.

Safety

Contraindications to LUGELA intake are:

• hypercalcemia;
• individual intolerance to components.

In complex chronic diseases, LUGELA is included in the current treatment program considering prescribed drugs and examination results.

Academic conclusion

Main sources

1. Marsell R., Einhorn T. A. The biology of fracture healing. Injury. 2011;42(6):551–555.
2. Schindeler A. et al. Bone remodeling during fracture repair: the cellular picture. Seminars in Cell & Developmental Biology. 2008;19(5):459–466.
3. Smolen J. S. et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Annals of the Rheumatic Diseases. 2023;82:3–18.
4. World Health Organization. Package of Interventions for Rehabilitation. Module 2: Musculoskeletal Conditions.
5. Dzhavakhishvili D. V. Mineral water LUGELA: characteristics and therapeutic properties. Tbilisi: Gruzmedgiz, 1953.
6. Balneological conclusion on natural mineral water LUGELA, 2023.
7. Medical conclusion on the use of natural mineral water LUGELA, 2023.
8. Protocol of chemical analysis of mineral water LUGELA, 2023.